A general practice trial of Ateroid 200 in 8,776 patients with chronic senile cerebral insufficiency.
Santini
V
V
Crinos Medical Department, Villa Guardia, Como, Italy.
D000368:Aged; D002986:Clinical Trials as Topic; D015161:Dementia, Multi-Infarct / Q000188:drug therapy* / Q000523:psychology; D015140:Dementia, Vascular / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006496:Heparinoids / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D009483:Neuropsychological Tests
D006025:Glycosaminoglycans; D006496:Heparinoids; D000960:Hypolipidemic Agents